BackOrchard Therapeutics plc Overview

Orchard Therapeutics plc Goodwill

Track Orchard Therapeutics plc's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Orchard Therapeutics plc Goodwill History

Loading

Orchard Therapeutics plc vs. peers: Goodwill Comparison

Loading

Orchard Therapeutics plc Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Orchard Therapeutics plc (ORTX) FAQ

Orchard Therapeutics plc (ORTX) currently reports a goodwill of $0 as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Orchard Therapeutics plc's goodwill history and peer comparisons.

Orchard Therapeutics plc's goodwill changed from $0 to $0 (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orchard Therapeutics plc reported $0 in goodwill as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orchard Therapeutics plc, and consider following ORTX for alerts when major investors trade the stock.

Orchard Therapeutics plc is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORTX with unrelated industries.